Targeting Myelogenous Leukemia Stem Cells: Role of the Circulation.
Unlike stem cells from solid tumors, the stem cells which initiate myelogenous leukemias arise in marrow, an organ with a unique circulation which allows ready access of leukemia cells, including leukemia stem cells, to the vasculature. This poses unique problems in the targeting of leukemic stem c...
Main Author: | Jane eLiesveld |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2012-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2012.00086/full |
Similar Items
-
Chronic myelogenous leukemia on target
by: Veronika Némethová, et al.
Published: (2018-07-01) -
Wnt Signaling Pathway and Chronic Myelogenous Leukemia
by: HOU Yan, et al.
Published: (2019-02-01) -
Leukemia and Benzene
by: Robert Snyder
Published: (2012-08-01) -
Identification of key candidate targets and pathways for the targeted treatment of leukemia stem cells of chronic myelogenous leukemia using bioinformatics analysis
by: Huayao Li, et al.
Published: (2019-09-01) -
Targeting Chronic Myeloid Leukemia Stem/Progenitor Cells Using Venetoclax-Loaded Immunoliposome
by: Mohammad Houshmand, et al.
Published: (2021-03-01)